Compass Therapeutics, Inc. (CMPX) Operating Income (Loss) USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Compass Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
  • Compass Therapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$12.8 M, a 31.5% decline year-over-year.
  • Compass Therapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$53.4 M, a 20.9% decline year-over-year.
  • Compass Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$50.4 M, a 20.9% decline from 2022.
  • Compass Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$41.7 M, a 49.1% increase from 2021.
  • Compass Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$81.9 M, a 194% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$53.4 M -$12.8 M -$3.06 M -31.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$50.4 M -$15.4 M -$2.5 M -19.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$47.9 M -$11.9 M +$672 K +5.33% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$48.5 M -$13.3 M -$4.35 M -48.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$44.2 M -$9.71 M -$2.53 M -35.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$41.7 M -$12.9 M +$112 K +0.86% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$41.8 M -$12.6 M -$6.74 M -115% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$35 M -$8.99 M +$46.7 M +83.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$81.7 M -$7.18 M +$157 K +2.14% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$81.9 M -$13 M -$5.05 M -63.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$76.8 M -$5.85 M +$3.11 M +34.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$79.9 M -$55.7 M -$50.6 M -998% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-01
Q1 2021 -$29.3 M -$7.34 M -$1.51 M -25.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$27.8 M -$7.95 M -$7.94 M -77552% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 -$19.9 M -$8.96 M -$578 K -6.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$19.3 M -$5.07 M +$3.6 M +41.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$22.9 M -$5.83 M -$5.82 M -74532% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 -$17.1 M -$10.2 K* -$971 -10.5% Oct 1, 2019 Dec 31, 2019 10-Q 2020-02-14
Q3 2019 -$17.1 M -$8.38 M -$8.38 M -107581% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$8.7 M -$8.67 M -$8.67 M -109768% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$32.8 K -$7.81 K Jan 1, 2019 Mar 31, 2019 10-K 2020-06-08
Q4 2018 -$9.27 K* Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 -$7.79 K* Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$7.89 K* Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.